NCT04077203

Brief Summary

This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 16, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 29, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 4, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
Last Updated

November 17, 2020

Status Verified

September 1, 2019

Enrollment Period

5 months

First QC Date

August 29, 2019

Last Update Submit

November 14, 2020

Conditions

Outcome Measures

Primary Outcomes (10)

  • Weight in kg

    Weight in kg

    2 weeks

  • Body Mass Index (BMI)

    Height in cm and weight in kg will be used to calculate BMI

    2 weeks

  • Body fat %

    Using a smart scale

    2 weeks

  • Resting heart rate

    Using a sphygmomanometer with heart rate sensor

    2 weeks

  • Resting blood pressure (systolic and diastolic)

    Using a sphygmomanometer

    2 weeks

  • Self-reported positive and negative affect

    Positive and Negative Affect Schedule (PANAS; Watson et al., 1988). The scale consists of 20 items (10 for Positive Affect; 10 for Negative Affect), with each item rated on a 5-point scale of 1 (not at all) to 5 (extremely). Items are summed for Positive affect and Negative affect, with higher scores indicating a higher level of affect in each respective scale.

    2 weeks

  • Self-reported general health

    12-Item Short-Form Health Survey (SF-12; Ware et al., 1996). The scale measures overall general self-reported physical and mental health using 12 items, on 2 to 6-point ordinal scales. The range of possible total scores is 12 to 48, with higher scores indicating better health.

    2 weeks

  • Self-reported perceived stress

    Perceived Stress Scale (Cohen et al., 1983; Cohen \& Williamson, 1988). This is a 4-item scale that measures overall stress with each item evaluated on a 5-point Likert scale. The range of possible total scores is 0 to 16, with higher scores indicating more stress.

    2 weeks

  • Self-reported sleep quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989). This is a 19-item scale that measures self-reported sleep quality and sleep disturbances, comprised of open-ended questions and scaled items evaluated on a 4-point Likert scale. The range of possible total scores is 0 to 21, with higher scores indicating poorer sleep quality.

    2 weeks

  • Self-reported general well-being

    Satisfaction with Life Scale (Diener et al., 1985). This is a 5-item scale that measures overall well-being with each item evaluated on a 7-point Likert scale. The range of possible total scores is 5 to 35, with higher scores indicating higher well-being.

    2 weeks

Study Arms (2)

Control

SHAM COMPARATOR

Those receiving no visual feedback because the handheld device monitor will be occluded with black tape (the control group).

Behavioral: Biofeedback / No biofeedback

Test

EXPERIMENTAL

Those receiving the ability to visualize their glucose levels via the handheld device (the biofeedback group).

Behavioral: Biofeedback / No biofeedback

Interventions

Biofeedback / No biofeedback

ControlTest

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Below the age of 18 years
  • Diagnosis of any known chronic or acute medical disease (e.g., diabetes, cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)
  • Diagnosis of any known neurological disease or psychological disorder (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)
  • Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)
  • Suspected or confirmed pregnancy
  • Currently breastfeeding
  • Use of antibiotics in the three months prior to enrollment
  • Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klick Inc.

Toronto, Ontario, M4W 3R8, Canada

Location

MeSH Terms

Interventions

Biofeedback, Psychology

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2019

First Posted

September 4, 2019

Study Start

July 16, 2019

Primary Completion

November 30, 2019

Study Completion

November 30, 2019

Last Updated

November 17, 2020

Record last verified: 2019-09

Locations